These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37445689)

  • 41. Activation of Autophagy Ameliorates Cardiomyopathy in
    Singh SR; Zech ATL; Geertz B; Reischmann-Düsener S; Osinska H; Prondzynski M; Krämer E; Meng Q; Redwood C; van der Velden J; Robbins J; Schlossarek S; Carrier L
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
    Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
    J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
    Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
    Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
    Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human
    Pioner JM; Vitale G; Steczina S; Langione M; Margara F; Santini L; Giardini F; Lazzeri E; Piroddi N; Scellini B; Palandri C; Schuldt M; Spinelli V; Girolami F; Mazzarotto F; van der Velden J; Cerbai E; Tesi C; Olivotto I; Bueno-Orovio A; Sacconi L; Coppini R; Ferrantini C; Regnier M; Poggesi C
    Circ Res; 2023 Mar; 132(5):628-644. PubMed ID: 36744470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy.
    Beltrami M; Fedele E; Fumagalli C; Mazzarotto F; Girolami F; Ferrantini C; Coppini R; Tofani L; Bertaccini B; Poggesi C; Olivotto I
    Circ Genom Precis Med; 2023 Aug; 16(4):363-371. PubMed ID: 37409452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy.
    Helms AS; Tang VT; O'Leary TS; Friedline S; Wauchope M; Arora A; Wasserman AH; Smith ED; Lee LM; Wen XW; Shavit JA; Liu AP; Previs MJ; Day SM
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
    Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
    J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.
    Roncarati R; Latronico MV; Musumeci B; Aurino S; Torella A; Bang ML; Jotti GS; Puca AA; Volpe M; Nigro V; Autore C; Condorelli G
    J Cell Physiol; 2011 Nov; 226(11):2894-900. PubMed ID: 21302287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic variations in carriers of predicted protein-truncating genetic variants in MYBPC3: an autopsy-based case series.
    Williams N; Marion R; McDonald TV; Wang D; Zhou B; Eng LS; Um SY; Lin Y; Ruiter K; Rojas L; Sampson BA; Tang Y
    Cardiovasc Pathol; 2018; 37():30-33. PubMed ID: 30282064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation.
    Kuster DW; Sadayappan S
    Pflugers Arch; 2014 Feb; 466(2):207-13. PubMed ID: 24327208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting the population for gene therapy with MYBPC3.
    Carrier L
    J Mol Cell Cardiol; 2021 Jan; 150():101-108. PubMed ID: 33049255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
    Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
    J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Variants and Mutational Analyses of Cardiac Myosin-binding Protein C (MYBPC3) Gene of Adult Bangladeshi Patients with Hypertrophic Cardiomyopathy.
    Banu LA; Masum MM; Rahman S; Mahbuba S; Hossain M; Hosen MJ; Banerjee SK; Adhikary DK; Habib SA; Sultana GN; Islam MN
    Mymensingh Med J; 2023 Apr; 32(2):520-526. PubMed ID: 37002766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy.
    Glazier AA; Thompson A; Day SM
    Pflugers Arch; 2019 May; 471(5):781-793. PubMed ID: 30456444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertrophic cardiomyopathy in
    Ananthamohan K; Stelzer JE; Sadayappan S
    J Cardiovasc Aging; 2024 Jan; 4(1):. PubMed ID: 38406555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
    Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J
    Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.